PSA Vice President Professor Mark Naunton MPS[/caption]
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...
Medicine safety – a new national priority
A watershed moment for patients, pharmacists and medicine safety was reached last week when federal, state and territory health ministers declared Medicine Safety and...
Resistance movement: Pharmacy’s fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...
Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
